|
SHROOM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.381100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438360E-02 |
| Normal-vs-Stage2 |
1.363220E-04 |
| Normal-vs-Stage3 |
2.38680000208547E-08 |
| Normal-vs-Stage4 |
2.04589999999172E-05 |
| Stage1-vs-Stage2 |
8.851700E-02 |
| Stage1-vs-Stage3 |
1.040520E-03 |
| Stage1-vs-Stage4 |
6.557000E-03 |
| Stage2-vs-Stage3 |
2.147200E-01 |
| Stage2-vs-Stage4 |
2.435000E-01 |
| Stage3-vs-Stage4 |
7.733200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.962800E-04 |
| Normal-vs-AfricanAmerican |
6.229300E-04 |
| Normal-vs-Asian |
2.26899999999919E-05 |
| Caucasian-vs-AfricanAmerican |
6.967400E-01 |
| Caucasian-vs-Asian |
2.263900E-03 |
| AfricanAmerican-vs-Asian |
4.365600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.66280000000385E-05 |
| Normal-vs-Female |
7.484100E-02 |
| Male-vs-Female |
3.493600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.421110E-03 |
| Normal-vs-Extreme_Weight |
2.041800E-02 |
| Normal-vs-Obese |
3.179800E-02 |
| Normal-vs-Extreme_Obese |
2.388900E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.670400E-01 |
| Normal_Weight-vs-Obese |
1.790950E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.623200E-01 |
| Extreme_Weight-vs-Obese |
7.423800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.045410E-01 |
| Obese-vs-Extreme_Obese |
1.442610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.228500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.702400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.30259999999261E-05 |
| Normal-vs-Age(81-100Yrs) |
2.15040000000055E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.523600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.844200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.475400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.102400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.423500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.955200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.040300E-03 |
| Normal-VS-Type2 PRCC |
7.03420000025545E-08 |
| Normal-VS-KIRP CIMP |
1.7751999999982E-05 |
| Normal-VS-Unclassified PRCC |
2.770100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.373900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.374000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.463800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.531400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.739800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.197400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27319998988185E-09 |
| Normal-vs-N1 |
9.50650003161968E-09 |
| Normal-vs-N2 |
1.654170E-02 |
| N0-vs-N1 |
7.677200E-01 |
| N0-vs-N2 |
6.439200E-01 |
| N1-vs-N2 |
4.508600E-01 |
|
|
